A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...

It has been another stellar week for Genedrive after it revealed signs of commercial traction for its technology, followed by ...

An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...

Bio-Gene Technology Ltd. ( ($AU:BGT) ) has shared an announcement. Bio-Gene Technology Limited reported significant progress in Q1 FY26, including ...

The government’s long-promised Gene Technology Bill, which aims to reform laws around genetic modification, has run into a ...

The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...

The long-awaited Gene Technology Bill has stalled because New Zealand First won’t support it as it stands. The sticking point ...